Statistics for Enzalutamide in the treatment of metastatic castrationally-resistant prostate cancer following previous chemotherapy

Total visits

views
Enzalutamide in the treatment of metastatic castrationally-resistant prostate cancer following previous chemotherapy 0

Total visits per month

views
November 2023 0
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0